Search results
Kong Lingquan is Board Member at Cardinal Resources Ltd. See Kong Lingquan's compensation, career history, education, & memberships.
- Board Member
- Cardinal Resources Ltd
Ling-quan Kong via Scopus - Elsevier Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis.
Lingquan Kong is Executive Director at Focus Minerals Ltd. See Lingquan Kong's compensation, career history, education, & memberships.
- Executive Director
- Focus Minerals Ltd
View Lingquan Kong’s profile on LinkedIn, a professional community of 1 billion members. Undergraduate of University of Cambridge · Experience: Medic Mind · Education: University of Cambridge...
- 31
- Medic Mind
- 华东师范大学第二附属中学
- Cambridge, England, United Kingdom
Lingquan KONG | Cited by 57 | of Chongqing Medical University, Chongqing | Read 15 publications | Contact Lingquan KONG
Ling-quan Kong's 60 research works with 551 citations and 3,070 reads, including: Partial primary osteoporosis maybe due to parathyroid hyperfunction caused by calcium intake insufficiency...
Lingquan Kong's 5 research works with 4 citations and 144 reads, including: Prevalence, Awareness, Treatment and the Hemoglobin A1c Diagnostic Cut-Off Points of Diabetes and Prediabetes in...
